Biogen And Eisai Say Alzheimer ' s Drug A Success, Reversing Earlier Result
A complicated new clinical trial could give some hope to Alzheimer ' s patients and investors in drug companies. But there are lots of devilish details.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NASDAQ:BIIB Source Type: news